Anthropic Stock—The Bull, Base And Bear Case Into Nasdaq-100 Entry
Anthropic stock (ANT) fell 27% from its high in 2 days. The full greenshoe removed underwriter support at $83. See the bull, base and bear cases for ANT.
Follow the latest Anthropic, PBC (ANT) news and market headlines alongside the live ANT price. Stay informed on what's moving ANT.
Anthropic stock (ANT) fell 27% from its high in 2 days. The full greenshoe removed underwriter support at $83. See the bull, base and bear cases for ANT.
https://x.com/Oracle/status/2123884437045760420
SOXX is down 34.5% in two months, a slump only September 2001 beat, as Nvidia loses $1 trillion in a week and the S&P 500 enters a correction.
Bloom Energy Corp. (NYSE: BE) shares are tumbling Friday as a sweeping AI selloff hits stocks tied to data center infrastructure.
GE Vernova Inc. (NYSE: GEV) shares are sinking Friday as a wider AI selloff weighs on stocks linked to data center infrastructure.
Tesla Inc. (NASDAQ: TSLA) shares are sliding Friday. A sweeping selloff in AI and growth stocks is weighing on the broader tech sector.
Besides Kutcher, two other celebrities likely saw a boost in their Anthropic stake valuations, including retired NBA star Tristan Thompson.
Broadcom stock dropped over 9% on Friday as a steep semiconductor selloff, AI spending concerns, and U.S.-China export rules weighed on tech shares. See what Dec. 9 earnings and Wall Street targets mean for AVGO.
Oracle Corp. (NYSE: ORCL) shares are tumbling Friday to a new 52-week low Friday along with other software stocks in a wider tech retreat.
Anthropic stock fell over 11% on Friday after Seaport Global initiated coverage with a Neutral rating. See why analyst Jay Goldberg flagged slowing revenue growth, $900 billion in compute commitments, and upcoming lock-up expirations.
Bitcoin, Ethereum and XRP fall 5% as an AI stock rout spills into crypto and Bitcoin searches for support below $60,000
Analysts initiated coverage: Neutral on Anthropic; Buy on Praxis ($713) and STMicro ($58); Overweight MSG Rangers ($310); Sector Perform Bruker ($66).
Cathie Wood says Anthropic's private AI models and heavy training investment could give it a lasting edge over open-weight rivals.
Anthropic's stock fell 8.7% on its second trading day as initial IPO excitement faded and broader AI stocks declined. Despite strong 47% sequential revenue growth, the company's compute spending grew 1.7x faster, causing it to swing from operating profit to operating loss. Investors are concerned about the company's long-term unit economics.
Cathie Wood's Ark Invest purchased 935,000 shares of Anthropic (ANT) during its IPO at $83 per share, while simultaneously selling some Nvidia (NVDA) shares. The move signals a shift in Wood's portfolio strategy, favoring the high-growth AI platform developer over the established chip manufacturer, despite Nvidia's valuation appearing attractive at less than 9 times next year's profit target.
Dan Ives names seven reasons why technology stocks are selling off. Staying bullish on the sector, Ives is focusing on the best names going forward.
The AI investment boom is blurring the boundaries between thematic ETFs, potentially leaving investors with exposures they might not expect.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to ANT, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.